Skip to main content
. 2024 May 13;14:10894. doi: 10.1038/s41598-024-60999-3

Table 5.

Association of AIP (per-0.1 unit increase) with the risk of primary endpoint according to the presentation of AMI.

Non-AMI (n = 7599) AMI (n = 3136)
HR (95% CI) P HR (95% CI) P
Model 1 0.94 (0.90–0.98) 0.002 0.98 (0.93–1.02) 0.254
Model 2 0.94 (0.90–0.98) 0.004 1.00 (0.95–1.05) 0.967
Model 3 0.94 (0.90–0.98) 0.003 1.00 (0.95–1.06) 0.883
Model 4 0.94 (0.90–0.98) 0.004 1.00 (0.95–1.06) 0.869
Model 5 0.96 (0.92–1.00) 0.076 1.01 (0.96–1.07) 0.702

AIP atherogenic index of plasma; AMI acute myocardial infarction; BMI body mass index; CI confidence interval; CTO chronic total occlusion; HPR high platelet reactivity; HR hazard ratio; LVEF left ventricular ejection fraction.

The adjusted variables for Models 1, 2, and 3 are the same as those in Table 2.

Model 4: Model 3 + adjusted for HPR, multivessel disease, bifurcation lesions, CTO lesions, number of stents, total stent length, and minimum stent diameter.

Model 5: Modle 4 + adjusted for LVEF.